Found: 215
Select item for more details and to access through your institution.
Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.
- Published in:
- 2002
- By:
- Publication type:
- journal article
2024: The year to take European action on diabetes to the next level.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Incretins and cardiovascular disease: to the heart of type 2 diabetes?
- Published in:
- Diabetologia, 2023, v. 66, n. 10, p. 1820, doi. 10.1007/s00125-023-05973-w
- By:
- Publication type:
- Article
Women in diabetes research: we can do better. Reply to Bonnefond A [letter].
- Published in:
- 2023
- By:
- Publication type:
- Letter
The European Diabetes Forum (EUDF): a forum for turning the tide on diabetes in Europe.
- Published in:
- Diabetologia, 2023, v. 66, n. 2, p. 247, doi. 10.1007/s00125-022-05831-1
- By:
- Publication type:
- Article
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- Diabetologia, 2022, v. 65, n. 12, p. 1925, doi. 10.1007/s00125-022-05787-2
- By:
- Publication type:
- Article
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis.
- Published in:
- Diabetologia, 2022, v. 65, n. 8, p. 1251, doi. 10.1007/s00125-022-05715-4
- By:
- Publication type:
- Article
Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy.
- Published in:
- Diabetologia, 2020, v. 63, n. 11, p. 2423, doi. 10.1007/s00125-020-05254-w
- By:
- Publication type:
- Article
How conclusive is the CONCLUDE trial?
- Published in:
- Diabetologia, 2020, v. 63, n. 4, p. 692, doi. 10.1007/s00125-020-05086-8
- By:
- Publication type:
- Article
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
- Published in:
- Diabetologia, 2017, v. 60, n. 6, p. 1102, doi. 10.1007/s00125-017-4251-1
- By:
- Publication type:
- Article
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 8, p. 941, doi. 10.1007/s00592-024-02300-6
- By:
- Publication type:
- Article
An Italian MODY family with proband and son carrying variants in GCK and HFN1A: is it a true case of digenic MODY?
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 1, p. 131, doi. 10.1007/s00592-023-02171-3
- By:
- Publication type:
- Article
De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes.
- Published in:
- Acta Diabetologica, 2023, v. 60, n. 1, p. 53, doi. 10.1007/s00592-022-01974-0
- By:
- Publication type:
- Article
Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3633, doi. 10.1111/dom.15703
- By:
- Publication type:
- Article
Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 5, p. 1714, doi. 10.1111/dom.15479
- By:
- Publication type:
- Article
Cardiovascular and renal outcomes with varying degrees of kidney disease in high‐risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE‐O trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 4, p. 1216, doi. 10.1111/dom.15417
- By:
- Publication type:
- Article
Challenges and opportunities in real‐world evidence on the renal effects of sodium‐glucose cotransporter‐2 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 177, doi. 10.1111/dom.14599
- By:
- Publication type:
- Article
Switching to iGlarLixi versus continuation of a daily or weekly glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) in insufficiently controlled type 2 diabetes: A LixiLan‐G trial subgroup analysis by HbA1c and GLP‐1 RA use at screening
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1331, doi. 10.1111/dom.14345
- By:
- Publication type:
- Article
Design and baseline characteristics of the AMPLITUDE‐O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon‐like peptide‐1 receptor agonist.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 2, p. 318, doi. 10.1111/dom.14223
- By:
- Publication type:
- Article
Early combination therapy delayed treatment escalation in newly diagnosed young‐onset type 2 diabetes: A subanalysis of the VERIFY study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 245, doi. 10.1111/dom.14192
- By:
- Publication type:
- Article
Impact of disease duration and β‐cell reserve on the efficacy of switching to iGlarLixi in adults with type 2 diabetes on glucagon‐like peptide‐1 receptor agonist therapy: Exploratory analyses from the LixiLan‐G trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1567, doi. 10.1111/dom.14068
- By:
- Publication type:
- Article
Efficacy and safety of once‐monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo‐controlled, 16‐week randomized dose‐finding study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1176, doi. 10.1111/dom.14020
- By:
- Publication type:
- Article
Effects of treatment with metformin and/or sitagliptin on beta‐cell function and insulin resistance in prediabetic women with previous gestational diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 648, doi. 10.1111/dom.13940
- By:
- Publication type:
- Article
Durability of glycaemic control with dapagliflozin, an SGLT2 inhibitor, compared with saxagliptin, a DPP4 inhibitor, in patients with inadequately controlled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2564, doi. 10.1111/dom.13841
- By:
- Publication type:
- Article
A pre‐specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 10, p. 2240, doi. 10.1111/dom.13800
- By:
- Publication type:
- Article
Sustained 52‐week efficacy and safety of triple therapy with dapagliflozin plus saxagliptin versus dual therapy with sitagliptin added to metformin in patients with uncontrolled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 883, doi. 10.1111/dom.13594
- By:
- Publication type:
- Article
Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: A multicentre retrospective study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 2, p. 252, doi. 10.1111/dom.13508
- By:
- Publication type:
- Article
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 11, p. 2532, doi. 10.1111/dom.13413
- By:
- Publication type:
- Article
Effect of once weekly dulaglutide by baseline beta‐cell function in people with type 2 diabetes in the AWARD programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 2023, doi. 10.1111/dom.13313
- By:
- Publication type:
- Article
Safety and tolerability of dapagliflozin, saxagliptin and metformin in combination: <italic>Post‐hoc</italic> analysis of concomitant add‐on versus sequential add‐on to metformin and of triple versus dual therapy with metformin.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1542, doi. 10.1111/dom.13258
- By:
- Publication type:
- Article
Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 6, p. 1479, doi. 10.1111/dom.13257
- By:
- Publication type:
- Article
Practical strategies for improving outcomes in T2DM: The potential role of pioglitazone and DPP4 inhibitors.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 4, p. 786, doi. 10.1111/dom.13169
- By:
- Publication type:
- Article
Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 12, p. 1781, doi. 10.1111/dom.13114
- By:
- Publication type:
- Article
Unlocking the opportunity of tight glycaemic control.
- Published in:
- Diabetes, Obesity & Metabolism, 2005, v. 7, p. S1, doi. 10.1111/j.1463-1326.2005.00528.x
- By:
- Publication type:
- Article
The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 5, p. 847, doi. 10.1007/s13300-022-01228-w
- By:
- Publication type:
- Article
Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID Future.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 9, p. 2289, doi. 10.1007/s13300-021-01114-x
- By:
- Publication type:
- Article
Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 11, p. 2465, doi. 10.1007/s13300-020-00926-7
- By:
- Publication type:
- Article
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Insulin secretory function is impaired in isolated human islets carrying the Gly(972)-->Arg IRS-1 polymorphism.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Phasic insulin release and metabolic regulation in type 2 diabetes.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Lipotoxicity in human pancreatic islets and the protective effect of metformin.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Effects of glucosamine infusion on insulin secretion and insulin action in humans.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxide.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Bedtime Insulin/Daytime Glipizide.
- Published in:
- Diabetes, 1995, v. 44, n. 2, p. 165, doi. 10.2337/diab.44.2.165
- By:
- Publication type:
- Article
In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Total Body Fat Content and Fat Topography Are Associated Differently With In Vivo Glucose Metabolism in Nonobese and Obese Nondiabetic Women.
- Published in:
- Diabetes, 1992, v. 41, n. 9, p. 1151, doi. 10.2337/diab.41.9.1151
- By:
- Publication type:
- Article